Neoadjuvant capecitabine (X), docetaxel (T)±trastuzumab (H) for patients (pts) with locally advanced breast cancer (LABC): preliminary safety and efficacy data from a multicentre phase II study

W.Lybaert; Wildiers; P.Neven; P.Clement; M.R.Christiaens; C.Weltens; R.Drijkoningen; C.Van Ongeval; A.Van Steen; R.Paridaens

首页> 外文期刊>European Journal of Cancer Supplements >Neoadjuvant capecitabine (X), docetaxel (T)±trastuzumab (H) for patients (pts) with locally advanced breast cancer (LABC): preliminary safety and efficacy data from a multicentre phase II study

【24h】

Neoadjuvant capecitabine (X), docetaxel (T)±trastuzumab (H) for patients (pts) with locally advanced breast cancer (LABC): preliminary safety and efficacy data from a multicentre phase II study

机译：新辅助卡培他滨（X），多西他赛（T）±曲妥珠单抗（H）用于局部晚期乳腺癌（LABC）的患者（pts）：一项来自多中心II期研究的初步安全性和有效性数据

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《European Journal of Cancer Supplements》 |2006年第2期|共2页
作者
W.Lybaert; Wildiers; P.Neven; P.Clement; M.R.Christiaens; C.Weltens; R.Drijkoningen; C.Van Ongeval; A.Van Steen; R.Paridaens;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. 375 PUBLICATION Neoadjuvant capecitabine (X) plus docetaxel (T) for patients (pts) with locally advanced breast cancer (LABC): preliminary safety and efficacy data [J] . European Journal of Cancer Supplements . 2005,第2期

机译：375出版物新辅助卡培他滨（X）联合多西他赛（T）用于局部晚期乳腺癌（LABC）的患者（pts）：初步安全性和有效性数据
2. TBCRC049: A phase II non-randomized study to assess the safety and efficacy of the combination of tucatinib and trastuzumab and capecitabine for treatment of leptomeningeal metastases in HER2 positive breast cancer TBCRC049: A phase II non-randomized study to assess the safety and efficacy of the combination of tucatinib and trastuzumab and capecitabine for treatment of leptomeningeal metastases in HER2 positive breast cancer [J] . Intelligence: A Multidisciplinary Journal . 2020,第期

机译：TBCRC049：II期非随机性研究，以评估Tucatinib和Trastuzumab和Capecitabine的组合的安全性和功效，用于治疗Her2阳性乳腺癌TBCRC049中的百分声膜转移：II期非随机性研究，以评估安全性和疗效 Tucatinib和Trastuzumab和Capecitabine的组合治疗HER2阳性乳腺癌中的百分症转移
3. Neoadjuvant capecitabine chemoradiation (X-RT) for patients (pts) with locally advanced breast cancer (LABC) failing anthracycline-based neoadjuvant therapy: findings from a prospective phase II trial [J] . M.D.F.Gaui, Amorim, R.Arcuri, European Journal of Cancer Supplements . 2006,第2期

机译：针对基于蒽环类新辅助疗法失败的局部晚期乳腺癌（LABC）的患者（pts）进行新辅助卡培他滨化学放疗（X-RT）：一项前瞻性II期临床试验的结果
4. Characterizing tumor changes during neoadjuvant treatment of locally advanced breast cancer patients (LABC) using dynamicenhanced magnetic resonance imaging (DE-MRI) [C] . Oana I. Craciunescu, Ellen L. Jones, Kimberly L. Blackwell, Society of Photo-Optical Instrumentation Engineers (SPIE);SPIE Proceedings . 2005

机译：使用动态增强磁共振成像（DE-MRI）表征局部晚期乳腺癌患者（LABC）新辅助治疗期间的肿瘤变化
5. A phase Ib study of safety and pharmacokinetics of trastuzumab emtansine and pertuzumab in Japanese patients with HER2-positive metastatic breast cancer [D] . NOGUCHI, Emi 2019

机译：Ib期研究曲妥珠单抗氨丹宁和帕妥珠单抗在日本HER2阳性转移性乳腺癌患者中的安全性和药代动力学
6. Efficacy Endpoints of RTOG 0247: A Randomized Phase II Study of Neoadjuvant Radiation Therapy Plus Concurrent Capecitabine and Irinotecan or Capecitabine and Oxaliplatin for Patients with Locally Advanced Rectal Cancer [O] . Stuart J. Wong, J. Moughan, Neal J. Meropol, -1

机译：RTOG 0247的疗效终点：新辅助放疗联合卡培他滨和伊立替康或卡培他滨和奥沙利铂治疗局部晚期直肠癌的II期随机研究
7. Epirubicin With Cyclophosphamide Followed by Docetaxel With Trastuzumab and Bevacizumab as Neoadjuvant Therapy for HER2-Positive Locally Advanced Breast Cancer or as Adjuvant Therapy for HER2-Positive Pathologic Stage III Breast Cancer: A Phase II Trial of the NSABP Foundation Research Group, FB-5 [O] . John W. Smith, Marc E. Buyse, Priya Rastogi, 2017

机译：环磷酰胺蛋白与环磷酰胺，其次是多西紫杉醇与Trastuzumab和Bevacizumab为Neoadjuvant治疗，用于Her2阳性局部晚期乳腺癌，或作为HER2阳性病理阶段III乳腺癌的辅助治疗：NSABP基金会研究组的II期试验，FB-5

Neoadjuvant capecitabine (X), docetaxel (T)±trastuzumab (H) for patients (pts) with locally advanced breast cancer (LABC): preliminary safety and efficacy data from a multicentre phase II study

著录项

相似文献

相关主题

期刊订阅